CN Patent

CN106860852A — 一种用于结合治疗胃病的粘液西药

Assigned to Individual · Expires 2017-06-20 · 9y expired

What this patent protects

本发明公开了一种用于结合治疗胃病的粘液西药，它由以下原料混合加工而成，各原料的重量配比如下：甲氧氯普胺片40～85mg、奥美拉唑30～50mg、氢氧化铝20～60mg、维生素B 2 8～30mg、胃膜素15～40mg、磷酸铝10～25mg、甲氧基丙氧基5～15mg、苯并咪唑钠盐25～60mg；本发明疗效稳定、标本兼治，服用方便、简单，无异味且无毒性副作用，安全可靠，制造工艺简单，生产成本低，具有消炎、止痛功效，适合胃病患者使用。

USPTO Abstract

本发明公开了一种用于结合治疗胃病的粘液西药，它由以下原料混合加工而成，各原料的重量配比如下：甲氧氯普胺片40～85mg、奥美拉唑30～50mg、氢氧化铝20～60mg、维生素B 2 8～30mg、胃膜素15～40mg、磷酸铝10～25mg、甲氧基丙氧基5～15mg、苯并咪唑钠盐25～60mg；本发明疗效稳定、标本兼治，服用方便、简单，无异味且无毒性副作用，安全可靠，制造工艺简单，生产成本低，具有消炎、止痛功效，适合胃病患者使用。

Drugs covered by this patent

vonoprazan-fumarate (VONOPRAZAN FUMARATE)

Patent Metadata

Patent number: CN106860852A
Jurisdiction: CN
Classification: —
Expires: 2017-06-20
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.